Vectors Research Management, LLC Astrazeneca PLC Transaction History

Vectors Research Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$47.16 - $54.44 $9,432 - $10,888	-200 Reduced 40.0%	300 $15,000
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $2,426 - $2,901	-50 Reduced 9.09%	500 $25,000
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $26,535 - $30,550	500 Added 1000.0%	550 $30,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $2,155 - $2,765	50 New	50 $3,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vectors Research Management, LLC with notifications on news.